Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities.
BACKGROUND
Stress is suggested to lead to metabolic dysregulations as clustered in the metabolic syndrome, but the underlying biological mechanisms are not yet well understood.


OBJECTIVE
We examined the relationship between two main str systems, the autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis, with the metabolic syndrome and its components.


METHODS
The design was baseline data (yr 2004-2007) of a prospective cohort: the Netherlands Study of Depression and Anxiety (NESDA).


METHODS
The study comprised general community, primary care, and specialized mental health care.


METHODS
This study included 1883 participants aged 18-65 yr.


METHODS
Autonomic nervous system measures included heart rate, respiratory sinus arrhythmia (RSA; high RSA reflecting high parasympathetic activity), and preejection period (PEP; high PEP reflecting low sympathetic activity). HPA axis measures included the cortisol awakening response, evening cortisol, and a 0.5 mg dexamethasone suppression test as measured in saliva. Metabolic syndrome was based on the updated Adult Treatment Panel III criteria and included high waist circumference, serum triglycerides, blood pressure, serum glucose, and low high-density lipoprotein cholesterol.


RESULTS
RSA and PEP were both independently negatively associated with the presence of the metabolic syndrome, the number of metabolic dysregulations as well as all individual components except high-density lipoprotein cholesterol (all P < 0.02). Heart rate was positively related to the metabolic syndrome, the number of metabolic dysregulations, and all individual components (all P < 0.001). HPA axis measures were not related to metabolic syndrome or its components.


CONCLUSIONS
Our findings suggest that increased sympathetic and decreased parasympathetic nervous system activity is associated with metabolic syndrome, whereas HPA axis activity is not.
Licht
Carmilla M M
CM
Department of Psychiatry/EMGO Institute, Vrije Universiteit Medical Center, AJ Ernststraat 887, 1081 HL Amsterdam, The Netherlands. c.licht@vumc.nl
Vreeburg
Sophie A
SA
van Reedt Dortland
Arianne K B
AK
Giltay
Erik J
EJ
Hoogendijk
Witte J G
WJ
DeRijk
Roel H
RH
Vogelzangs
Nicole
N
Zitman
Frans G
FG
de Geus
Eco J C
EJ
Penninx
Brenda W J H
BW
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000503:physiopathology*; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D001341:Autonomic Nervous System / Q000502:physiology / Q000503:physiopathology; D049628:Body Size; D008076:Cholesterol, HDL / Q000097:blood; D003863:Depression / Q000503:physiopathology*; D005260:Female; D006339:Heart Rate; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology / Q000503:physiopathology*; D008297:Male; D024821:Metabolic Syndrome / Q000503:physiopathology*; D008875:Middle Aged; D018579:Patient Selection; D010913:Pituitary-Adrenal System / Q000502:physiology / Q000503:physiopathology*; D014280:Triglycerides / Q000097:blood; D055815:Young Adult
D008076:Cholesterol, HDL; D014280:Triglycerides; D006854:Hydrocortisone